MedTrace Logo

A Pharmacokinetics Study of Meropenem and Piperacillin in Patients With Sepsis

NCT05807217 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2023-04-11

No results posted yet for this study

Summary

This study was a single-center, open clinical study in Chinese septic patients with or without acute kidney injury. The aims of this study were to obtain the blood concentration and pharmacokinetic parameters of meropenem and piperacillin, exosome information and endogenous biomarker, and to explore the functional changes of OATs under the condition of sepsis and acute kidney injury.

Conditions

Sponsors & Collaborators

  • Shen Ning

    lead OTHER

Principal Investigators

  • Ning shen · Peking University Third Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-26
Primary Completion
2023-11-30
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05807217 on ClinicalTrials.gov